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Background/aim: The aim of this study was to evaluate return visits to the pediatric emergency department (ED) for children who were
detected to be positive for SARS-CoV-2 by polymerase chain reaction (PCR).
Materials and methods: Between April 2, 2020, and January 20, 2021, children aged 0 to 18 years who were detected to be SARS-CoV-2
PCR-positive and discharged from the ED were evaluated. Among them, patients who returned to the ED within 14 days of quarantine
were included in the study. For the first presentation and return visit, demographics, clinical findings, laboratory and radiologic
investigations, and ward/pediatric intensive care unit (PICU) admissions were recorded. Patients were divided into 5 groups according
to clinical severity.
Results: Among 575 children who were confirmed to be SARS-CoV-2 PCR-positive, 50 (8.6%) of them [median age: 10.4 years (IQR:
4.8–15.2); 26 females] had returned. There was no difference for age, sex, underlying diseases, or symptoms for patients who returned
or did not for the first presentation, but the percentage of those from whom laboratory tests were obtained was higher in cases of return
visits. For symptomatic cases on the first presentation, the most common reason for return was having additional symptoms. The most
common symptoms at the return visit were fever, cough, and sore throat. There was no severe/critical case in terms of clinical severity.
Among all cases, 36 (72.0%) patients were discharged from the ED, 13 (26.0%) were observed for 6–8 h and then discharged, and 1
(2.0%) was admitted to the ward; there was no PICU admission or death, respectively.
Conclusion: Patients who returned to the ED had mild clinical presentations. Understanding the frequency of and risk factors for return
visits can clarify public health priorities such as healthcare planning to ensure the availability of resources needed for acute and followup care of children with COVID-19.
Key words: Children, COVID-19, SARS-CoV-2, return, emergency department, pandemic

1. Introduction
Coronavirus disease 2019 (COVID-19), caused by severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2),
has rapidly evolved into a pandemic and has been an
emerging disease of global public health concern. As it
is regarded as a pandemic, huge challenges still exist for
global prevention and control strategies [1,2]. COVID-19
has caused an unprecedented health crisis worldwide.
There has been substantial pressure on healthcare systems
to meet the escalating demands from the swelling pandemic
surge [3].
As the incubation period ranges between 1 and 14
days, many of the COVID-19 patients who are discharged
are recommended to undergo a 14-day quarantine and
treatment at home [4–6]. However, some patients with
COVID-19 may develop serious illness several days after
the initial symptoms [7]. Limited data exist on whether

these patients fully recover or if they re-present to the
emergency department (ED) [4–6]. Return visits of
patients with COVID-19 disease have been a common and
costly public health concern that endangers patient safety
and may further drain hospital resources during this public
health emergency period. Understanding the associations
of COVID-19 with return visits may have useful
implications for policy-making in an effort to optimize
healthcare delivery [8]. Concerns for surges in hospital
occupancy force emergency providers to preserve inpatient
resources [7]. Published data mostly include information
on the clinical course, laboratory and radiologic results,
and treatment of patients with COVID-19 [4–6]. However,
to date, there is a relative paucity of data on studies focusing
on representations of COVID-19 patients.
The aim of this study was to evaluate characteristics
of return visits to the pediatric ED within 14 days of
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discharge for children who were detected to be SARSCoV-2 polymerase chain reaction (PCR)-positive.
2. Materials and methods
2.1. Study design
This was a single-center retrospective study performed in
the pediatric ED of a tertiary hospital with approximately
120,000 pediatric emergency department visits per annum.
The study was approved by the local ethics committee
(approval number: 2020/30-03).
The study population included children aged 0 to
18 years who presented to the pediatric ED and were
diagnosed as SARS-CoV-2 reverse-transcription PCRpositive with a confirmed nasopharyngeal specimen based
on the guidelines published by the Ministry of Health’s
Scientific Committee, then discharged from the ED with
quarantine recommendations. Among them, those who
returned to the pediatric ED within 14 days of quarantine
were included in the study.
We used International Classification of Diseases
codes for COVID-19 to identify patients. We obtained
information from a computer database and electronic
medical records. Patients who were diagnosed with
COVID-19 in another facility, those for whom a control
visit was planned by our medical staff after discharge from
the ED, and those with insufficient data were excluded.
For the first presentation and the return visit,
demographics, presence of chronic illness, symptoms with
duration, history of contact with suspected/confirmed
COVID-19 cases, and the presence of an individual in
the patient’s household in quarantine, hospitalized in a
ward/intensive care unit, or who had died were recorded.
The time between the first presentation and return was
calculated. Because symptoms of sore throat or smell/taste
loss cannot be described by infants and preschool-aged
children, patients over the age of 3 years were asked about
sore throat, while patients of 5 years and older were asked
about smell/taste loss. Cases were divided into 4 age groups
as ≤1 year, 1–6 years, 6–10 years, and >10 years. Clinical
findings, laboratory data, radiologic investigations, and
diagnoses for both the first presentation and the return visit
were recorded. According to clinical severity, patients were
divided into 5 groups as asymptomatic, mild, moderate,
severe, or critical as previously described [9]. In addition,
patients did not receive specific treatment for COVID-19.
Reasons for return were divided into 5 groups as follows:
Group 1: Those who had additional symptoms while
being symptomatic at the time of the first presentation.
Group 2: Those who became symptomatic while being
asymptomatic at the first presentation. Group 3: Those
who had aggravation of symptoms without any different
symptoms from the time when the first presentation
occurred. Group 4: Those with ongoing symptoms,

without aggravation or any additional symptoms. Group
5: Any other reason.
For the return visit, patients were divided into 3 groups
according to the final decision that was made: Group 1:
Discharged from the ED. Group 2: Observed for 6–8
h in the ED and then discharged. Group 3: Admitted to
the hospital [ward/pediatric intensive care unit (PICU)].
Finally, the need for respiratory support, length of stay in
the hospital, and prognosis were recorded.
2.2. Statistical analysis
All statistical analyses were performed using SPSS 22.0
software for Windows (IBM Corp., Armonk, NY, USA).
Categorical and continuous variables were reported as
frequencies and percentiles and as means with standard
deviations (SDs) or medians with interquartile ranges
(IQRs). The Mann-Whitney U test was used to compare
nonparametric data and student’s t-test was used for
parametric data. A value of p < 0.05 was considered
statistically significant.
3. Results
During the study period, 575 children were confirmed to be
PCR-positive for SARS-CoV-2 and were discharged from
the pediatric ED. Among them, 50 (8.6%) returned to the
ED within 14 days of quarantine. There was no difference
for age, sex, history of contact with suspected/confirmed
COVID-19 cases, underlying diseases, symptoms, or
radiologic investigations for patients who returned or
did not follow the first presentation, but the percentage
of those from whom laboratory tests were obtained was
higher for patients who returned to the ED, as shown in
Table 1.
Twenty-six (52.0%) of the patients were female and
the median age was 10.4 years (IQR: 4.8–15.2). The most
common age group was >10 years with 28 (56.0%) patients,
followed by 1–6 years (n: 12, 24.0%) and 6–10 years (n: 10,
20.0%); there was no patient under the age of 1 year. Nine
(18.0%) of the patients had chronic illnesses, as shown in
Table 2. The time between the first presentation and return
visit was a median of 6.0 days (IQR: 2.7–10.0), as shown
in Table 3.
Evaluating the first presentation of these patients,
36 (72.0%) were symptomatic and the most common
symptom was fever (n: 19, 38.0%), followed by cough (n: 9,
18.0%), sore throat (n: 9, 18.0%), and fatigue (n: 9, 18.0%).
Twenty-nine (58.0%) of them had contact with a SARSCoV-2 PCR-positive individual who was symptomatic in
28 (96.5%) cases and a household member in 26 (89.6%)
cases. Among household individuals, 47 (94.0%) were in
quarantine and 3 (6.0%) had been admitted to the ward.
The diagnosis was upper respiratory tract infection in
31 (62.0%) cases and acute gastroenteritis in 5 (10.0%).
Laboratory tests were obtained from 14 (28.0%) patients
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Table 1. Demographics, clinical findings, and presence of laboratory/radiological investigations of the patients who returned or not in
the study.
Parameter

Return visit (+)
n: 50

Return visit (-)
n: 525

p

Age in years, median (IQR)

10.4 (4.8–15.2)

12.0 (4.2–15.1)

0.616

Female sex, n (%)

26 (52.0)

280 (53.3)

0.477

Contact with a COVID-19 PCR-Positive individual, n (%)

29 (58.0)

307 (58.4)

0.560

Underlying disease, n (%)

9 (18.0)

55 (10.5)

0.185

Presence of any symptom at first admission, n (%)

36 (72.0%)

414 (78.8)

0.401

Laboratory investigations at first admission, n (%)

25 (50.0)

167 (31.8)

0.005

Lymphocyte count/mm3, median (IQR)

2300 (1800–2900)

1300 82100–2900)

0.576

C-reactive protein (mg/L), median (IQR)

1.3 (0.7–4.0)

4.1 (1.0–10.5)

0.043

Procalcitonin (ng/mL), median (IQR)

0.03 (0.01–0.04)

0.05 (0.02–0.10)

0.016

Radiological investigations at first admission, n (%)

11 (22.0)

123 (23.4)

0.137

IQR: Interquartile range

and radiologic investigations were performed for 11
(22.0%), the latter being chest X-ray for 10 (20.0%) patients
and computed tomography (CT) for 1 (2.0%) patient, as
shown in Table 2.
Evaluating return visits, the most common reason was
additional symptoms for cases that were symptomatic at
the time of the first presentation with 29 (58.0%) patients.
There were 9 (18.0%) patients who became symptomatic
while being asymptomatic at the first presentation and
8 (16.0%) patients who had aggravation of symptoms
without any different symptoms from the time when the
first presentation occurred. Three (6.0%) patients returned
with ongoing symptoms, without aggravation or any
additional symptom. Finally, there was 1 patient with an
“other” reason: a 6-year-old boy with hemophilia who
had fallen and needed factor replacement. The family was
usually able to provide factor treatment intravenously at
home, but he was admitted to the ED because of absence
of intravenous access.
The most common symptoms at return visits were
fever (n: 15, 30.0%), cough (n: 9, 18.0%), and sore throat
(n: 8, 16.0%). The median time for onset of new symptoms
or aggravation of symptoms was 2.0 days (IQR: 1.0–2.0).
Laboratory tests were obtained in 30 (60.0%) cases and
radiologic investigations were performed in 19 (38.0%)
cases, the latter being chest X-ray for 17 (34.0%) patients
and CT for 2 (4.0%) patients. Compared with the first
presentation, there was an increase in the percentage
of patients from whom laboratory tests or radiologic
investigations were obtained for return visits. For 26
(52.0%) patients, the diagnosis was the same as in the
first presentation. Additionally, 13 (26.0%) patients were
diagnosed with upper respiratory tract infection, 5 (10.0%)
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with anxiety, and 4 (8.0%) with acute gastroenteritis.
All patients with anxiety were adolescents aged between
15 and 17 years old. For 6 (12.0%) patients, more than 1
return visit occurred. According to clinical severity, 48
(96.0%) of the patients were in the mild and 2 (4.0%) in
the moderate group; there was no severe or critical case in
terms of clinical severity.
There was no need for respiratory support for any
patient in return visits. Of all patients, 36 (72.0%) were
discharged from the pediatric ED, 13 (26.0%) were
observed for 6–8 h and then discharged, and 1 (2.0%) was
admitted to the ward; there was no PICU admission, as
shown in Table 3. The patient admitted to the ward was a
3-year-old boy with Wilms tumor who had a runny nose
upon the first presentation to the ED. On the 10th day of
the quarantine, he had developed neutropenic fever, so he
was admitted to the ward and piperacillin-tazobactam was
started. He was discharged without any complications. No
patients died during the return visit period.
4. Discussion
The COVID-19 pandemic has led to catastrophic effects
for global health worldwide. Many healthcare facilities
remain stretched beyond their capacity. Return visits to
EDs have the potential to exacerbate this burden and may
represent missed opportunities to provide optimal care
[10]. Understanding the epidemiology of returns among
COVID-19 patients would allow the healthcare system
to focus its already limited resources and may improve
outcomes during such a pandemic [11].
To the best of our knowledge, this is the first study
evaluating return visit characteristics of children with
COVID-19. Although limited, adult studies exist in the
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Table 2. Demographics, history of contact with a COVID-19-positive individual, and clinical
findings of the patients for the first presentation to the pediatric emergency department.
Variable

n: 50

Female sex, n (%)

26 (52.0)

Age in years, median (IQR)

10.4 (IQR: 4.8–15.2)

Age group, n (%)
0–1 year

-

1–6 years

12 (24.0)

6–10 years

10 (20.0)

>10 years

28 (56.0)

Underlying disease, n (%)

9 (18.0)

Contact with a COVID-19 PCR-positive individual, n (%)

29 (58.0)

In-house, n (%)

26 (76.6)

Symptoms, n (%)
Fever

19 (38.0)

Cough

9 (18.0)

Fatigue

9 (18.0)

Sore throat

9 (18.0)

Runny nose

6 (12.0)

Abdominal pain

4 (8.0)

Taste/smell loss

4 (8.0)

Headache

4 (8.0)

Diarrhea

2 (4.0)

Nausea/vomiting

2 (4.0)

Households, n (%)
In quarantine

47 (92.0)

Admitted to the ward

3 (6.0)

Admitted to the intensive care unit

-

Exitus

-

Laboratory tests, n (%)

14 (28.0)

Radiologic investigations, n (%)

11 (22.0)

Chest X-ray

10 (20.0)

Chest computed tomography

1 (2.0)

Diagnosis, n (%)
Asymptomatic infection

14 (28.0)

Upper respiratory tract infection

31 (62.0)

Acute gastroenteritis

5 (10.0)

IQR: Interquartile range.

literature that have evaluated returns to EDs or ward/
intensive care unit readmissions of COVID-19 patients.
Discussing return visits for children with COVID-19 is
challenging, as we do not yet have enough information
on the clinical characteristics of the disease or established
treatment regimens and care bundles. Therefore, it is

difficult to analyze and discuss the factors contributing to
the occurrence of return visits for the pediatric population.
Ye et al. reported that 11.0% of adults had returned to
the ED within 14 days and, of these, 7.6% were readmitted
to the hospital [12]. In a Spanish study, it was reported that
20.5% of discharged patients revisited the ED, mainly for
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Table 3. Return visit characteristics of the patients in the study.
Variable

n: 50

The time between first presentation and return visit (days), median (IQR)

6.0 (2.7–10.0)

More than one return visit, n (%)

6 (12.0)

Reason for a return visit, n (%)
Had additional symptoms while being symptomatic at the first presentation

29 (58.0)

Became symptomatic while being asymptomatic at the first presentation

9 (18.0)

Aggravation of symptoms without any different symptoms from the time when the first presentation occurred

8 (16.0)

Ongoing symptoms without aggravation or any additional symptoms

3 (6.0)

Other

1 (2.0)

Symptoms, n (%)
Fever

15 (30.0)

Cough

9 (18.0)

Sore throat

8 (16.0)

Fatigue

6 (12.0)

Abdominal pain

6 (12.0)

Shortness of breath

6 (12.0)

Diarrhea

5 (10.0)

Chest pain

4 (8.0)

Headache

3 (6.0)

Nausea/vomiting

3 (6.0)

Palpitation

3 (6.0)

Runny nose

3 (6.0)

Taste/smell loss

2 (4.0)

Rash

2 (4.0)

Time for the onset of new symptoms or aggravation of symptoms (days), median (IQR)

2.0 (1.0–2.0)

Laboratory tests, n (%)

30 (60.0)

Radiologic investigations, n (%)

19 (38.0)

Chest X-ray

17 (34.0)

Chest computed tomography

2 (4.0)

Diagnosis, n (%)
Same as the first presentation

26 (52.0)

Upper respiratory tract infection

13 (26.0)

Psychiatric aggravation

5 (10.0)

Acute gastroenteritis

4 (8.0)

Clinical severity, n (%)
Mild

48 (96.0)

Moderate

2 (4.0)

Severe/critical

-

The final decision, n (%)
Discharged from the pediatric emergency department

36 (72.0)

Observed for 6–8 h and then discharged

13 (26.0)

Admitted to the ward

1 (2.0)

Admitted to the PICU

-

IQR: Interquartile range, PICU: Pediatric intensive care unit.
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persistence or progression of symptoms, and among them,
38.8% were hospitalized [13]. We found a return visit rate
of 8.6% for children at a median of 6 days after discharge
from the ED and, for 12.0% of the patients, returns
occurred more than once.
Among published studies, the most common reasons
for returns were respiratory distress, pain, altered mental
status, falls, fever, soft tissue infection, thrombotic events,
and gastrointestinal symptoms [6,10,14–17]. In a Spanish
study, ED revisits were associated with a history of
rheumatologic disease, digestive symptoms, a respiratory
rate of >20 breaths/min, and corticosteroid therapy given
in the emergency department; in addition, age of >48 years
and fever were associated with hospitalization after ED
readmission [13]. Kilaru et al. reported that age, abnormal
chest X-ray findings, and fever or hypoxia on presentation
were independently associated with an increased rate
of return to the ED [7]. A recent analysis found chronic
conditions to be associated with hospital readmissions,
which could be explained by the complications of
underlying diseases in the presence of COVID-19 [15].
The most common reasons for readmission were reported
as respiratory distress and thrombotic episodes in another
analysis, while those happening at a later time (>12 days
after discharge) included exacerbations of psychiatric
illness and falls [3]. Somani et al. reported that rates of
intensive care unit admission and death were 5.8% and
3.6% on returns. In our study, the most common reason
was having additional symptoms for cases symptomatic at
the time of the first presentation and the most common
symptoms were fever, cough, fatigue, and sore throat.
There was no need for respiratory support and no severe/
critical case in our study, and only one patient was
admitted to the ward; there was also no PICU admission
or death. This could be related to the fact that children
usually have a milder clinical course than adults, which
seems to continue holding true for return visits. In our
study, the percentage of those from whom laboratory tests
were obtained was higher among patients who returned to
the ED, but there was no difference for initial symptoms,
age, or percentage of chronic diseases between those
who returned and those who did not. Cases for which
laboratory tests were obtained were not severe/critical at
the first presentation or for the return visit. In addition,
compared with the first presentation, there was an increase
in the percentage of patients for whom laboratory tests or
radiologic investigations were performed for return visits.
Hence, further examinations at the first presentation may
have increased the anxiety levels of these patients; more
detailed information and support should be provided to
patients about the postdischarge process. Increased rates

of laboratory or radiologic tests may also pose a risk of
increased workload for EDs and healthcare costs. This is
important for healthcare planning to ensure the availability
of resources needed during a pandemic.
In adult studies, it was suggested that at least 20% of
patients had elevated anxiety and depressive symptoms
after hospitalization for pneumonia and acute coronary
syndromes [18,19]. Ye et al. found that 10% of patients
screened positive for anxiety, depression, and loneliness
after discharge [12]. Likewise, 10.0% of our patients
returned to the ED with anxiety; all of these were
adolescents who did not have any known psychiatric
disorders and had not experienced anxiety before. A
higher level of care can be provided at home for these
patients. During the COVID-19 pandemic, it was reported
that patients were more likely to call their primary
care providers or the hospital helpline before deciding
to seek care in EDs [9]. Therefore, implementation
of telemedicine in ED practice to decrease the
anxiety might be an important point for those with
elevated anxiety.
Patients may have an unplanned return for any reason,
and the uncertain natural history of the disease may
make it difficult for emergency providers to predict which
patients will worsen among those who initially appear
well [7]. Hence, knowledge about the characteristics
of patients who are most at risk of return could help to
better decide when to discharge patients and how to select
those who need closer follow-up after discharge [16].
Meanwhile, return hospital visits do not equate to a failure
inpatient care; rather, this outcome represents the need
for a higher level of care than can be provided at home
[7]. Risk stratification may further improve the efficacy of
home monitoring and telemedicine services by focusing
attention on patients at higher risk of deterioration [7].
It should be noted that the learning curve for
COVID-19 has changed over the course of the pandemic,
which may have had a varying impact on patient discharge.
Concerns about gaps in postdischarge care for COVID-19
patients and an uncertain clinical course have had the
potential to delay hospital discharges [12]. There were
previously limited published guidelines for safe discharge
parameters for COVID-19 patients and few known risk
factors for return visits [12]. We need to be alert to the fact
that these patients could infect other people during return
processes. Reducing preventable ED revisits may draw
policy attention as an opportunity to improve the quality
of care and reduce healthcare costs [20].
We acknowledge the limitations of our study.
The number of patients who returned was limited.
Furthermore, during the study period, there was no strict
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protocol for hospitalization or discharge of the patients;
the decision was reserved for the judgment of individual
physicians.
In conclusion, patients who returned to the ED had
a mild clinical presentation and there was no need for
respiratory support and no PICU admission or mortality;
there was also an increase in the percentage of patients
for whom laboratory or radiologic tests were performed
during return visits. Understanding the frequency of
and risk factors for return visits can help shape public

health priorities such as healthcare planning to ensure the
availability of resources needed for acute and follow-up
care of children with COVID-19.
Funding
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